Biomolecules

Scope & Guideline

Transforming biochemical understanding through collaborative research.

Introduction

Welcome to your portal for understanding Biomolecules, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherMDPI
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationBIOMOLECULES / Biomolecules
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND

Aims and Scopes

The journal "Biomolecules" aims to publish high-quality research articles that focus on the molecular aspects of biological processes. It encompasses a wide range of topics related to biomolecular interactions, signaling pathways, and the development of biomolecular therapeutics.
  1. Molecular Biology and Biochemistry:
    Research focusing on the molecular mechanisms underlying biological processes, including gene expression, protein interactions, and enzyme functions.
  2. Biomolecular Therapeutics:
    Studies aimed at developing therapeutic agents derived from biomolecules, including peptides, proteins, and nucleic acids, for treating various diseases.
  3. Cancer Biology and Therapeutics:
    Investigations into the molecular mechanisms of cancer development, progression, and treatment, including the role of biomarkers and therapeutic targets.
  4. Neurobiology and Neurodegenerative Diseases:
    Research exploring the molecular basis of neurodegenerative diseases, neuroprotection, and the role of biomolecules in neuronal health.
  5. Metabolism and Metabolic Disorders:
    Studies on metabolic pathways, disorders like diabetes, and the role of biomolecules in regulating metabolism and associated diseases.
  6. Plant Biology and Biotechnology:
    Research on plant biomolecules, their roles in stress responses, and potential applications in agriculture and medicine.
  7. Microbiology and Infectious Diseases:
    Studies focusing on microbial interactions, pathogenesis, and the development of antimicrobial agents derived from biomolecules.
The journal has seen a rise in interest towards several emerging themes, reflecting current trends in biomolecular research. These areas highlight the innovative approaches and interdisciplinary nature of contemporary studies.
  1. Artificial Intelligence in Drug Discovery:
    Increasing incorporation of AI and machine learning techniques in drug discovery and biomolecular research, allowing for more efficient identification of therapeutic targets and drug interactions.
  2. Microbiome Research:
    A surge in studies focusing on the human microbiome and its connections with health, disease, and therapeutic interventions, highlighting the importance of microbial communities in various biological processes.
  3. Biomarkers in Disease Management:
    Growing emphasis on the identification and validation of biomarkers for early diagnosis, prognosis, and monitoring of treatment responses across various diseases, particularly in oncology.
  4. Extracellular Vesicles in Disease Pathogenesis:
    Increased research into the role of extracellular vesicles in cell communication and their implications in disease mechanisms, particularly in cancer and neurodegenerative diseases.
  5. Integrative Multi-Omics Approaches:
    A trend towards using multi-omics strategies (genomics, transcriptomics, proteomics, and metabolomics) to gain comprehensive insights into complex biological systems and disease states.
  6. Sustainable and Green Chemistry:
    A rise in studies focusing on green synthesis methods and the use of bioactive compounds from natural sources, reflecting a global push towards sustainability in scientific research.

Declining or Waning

While "Biomolecules" continues to cover a broad array of topics, certain themes have shown a decline in recent publications. These waning areas reflect shifts in research focus and emerging priorities in biomolecular research.
  1. Traditional Drug Discovery Approaches:
    There has been a noticeable decrease in studies focusing on conventional drug discovery methods as research increasingly emphasizes innovative approaches such as machine learning and computational modeling.
  2. Basic Structural Biology:
    Research that solely focuses on the basic structural aspects of biomolecules without considering their functional implications has become less prominent, as studies now often integrate functional and structural analyses.
  3. Plant Secondary Metabolites:
    While still relevant, the volume of studies specifically dedicated to plant secondary metabolites has decreased, possibly due to a shift towards more comprehensive investigations that include primary metabolism and its implications.
  4. Animal Models in Basic Research:
    The reliance on traditional animal models is waning as there is a growing emphasis on alternative models such as organoids and in vitro systems that better mimic human physiology.

Similar Journals

Cell Reports

Connecting Scientists to Transformative Discoveries
Publisher: CELL PRESSISSN: 2211-1247Frequency: 48 issues/year

Cell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.

Life Science Alliance

Catalyzing Breakthroughs in Molecular Biology and Health.
Publisher: LIFE SCIENCE ALLIANCE LLCISSN: Frequency: 6 issues/year

Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.

EMBO JOURNAL

Advancing the frontiers of biochemistry and molecular biology.
Publisher: WILEYISSN: 0261-4189Frequency: 24 issues/year

The EMBO JOURNAL, published by Wiley in Germany, is a renowned scientific journal that has been at the forefront of research in the fields of biochemistry, genetics, and molecular biology since its inception in 1982. With an impressive convergence of contributions leading up to 2024, this journal is recognized for its high impact, reflected in its Q1 rankings across multiple categories including Immunology, Molecular Biology, and Neuroscience. It holds a prestigious place in the academic community, standing out with an exemplary Scopus ranking of #3 in General Immunology and Microbiology and #6 in General Neuroscience, making it a critical resource for researchers, professionals, and students alike. The journal aims to publish transformative research that sheds light on the underlying mechanisms of biological processes, thus advancing our understanding of health and disease. While currently not offering open access, the EMBO JOURNAL continues to facilitate a rich exchange of knowledge through its rigorous peer-review process and commitment to excellence.

MOLECULAR BIOLOGY OF THE CELL

Innovating Insights into Cellular Mechanisms
Publisher: AMER SOC CELL BIOLOGYISSN: 1059-1524Frequency: 13 issues/year

MOLECULAR BIOLOGY OF THE CELL is a prestigious journal published by the American Society for Cell Biology, focusing on the latest advancements in cell biology and molecular biology. Established in 1990, this journal serves as a vital forum for disseminating innovative research, methodologies, and insights that drive the understanding of cellular processes and their implications in health and disease. With a noteworthy impact factor and recognition within the top quartiles for both Cell Biology and Molecular Biology, it ranks prominently among its peers, with Scopus rankings reflecting its significance in the scientific community. Although the journal does not follow an open access model, it provides essential access options for both institutional and personal subscriptions. Researchers, professionals, and students seeking to expand their knowledge and collaborate on groundbreaking findings will find MOLECULAR BIOLOGY OF THE CELL an invaluable resource in the field.

IUBMB LIFE

Transforming Insights into Impactful Science
Publisher: WILEYISSN: 1521-6543Frequency: 12 issues/year

IUBMB LIFE is a prestigious, peer-reviewed journal published by WILEY, dedicated to advancing the fields of biochemistry, molecular biology, and cell biology. With an impressive impact factor and consistently ranked in the Q1 and Q2 categories across multiple relevant disciplines—including Biochemistry, Genetics, and Clinical Biochemistry—this journal has established itself as a leading platform for disseminating innovative research and critical reviews that propel scientific discovery. The journal spans a converged publication period from 1999 to 2024, providing comprehensive insights into the dynamic landscape of biochemical research. Researchers, professionals, and students alike are invited to explore its Open Access options, ensuring that groundbreaking studies are accessible to a global audience. As it continues to shape the future of life sciences, IUBMB LIFE remains a vital resource for those seeking to enrich their understanding and contribute to these rapidly evolving fields.

Journal of Cell Communication and Signaling

Advancing the Frontiers of Cellular Dialogue
Publisher: SPRINGERISSN: 1873-9601Frequency: 4 issues/year

The Journal of Cell Communication and Signaling is a prestigious academic journal published by Springer, focused on advancing the understanding of cellular communication mechanisms and signaling pathways. Since its inception in 2007, this journal has established itself as a leading platform in the field, with a strong impact reflected in its 2023 categorizations: Q1 in Biochemistry, Q2 in Cell Biology, and Q2 in Molecular Biology. Researchers from around the globe rely on its rigorous peer-reviewed articles to gain insights into the complex molecular dialogue that underpins various biological processes. With an ISSN of 1873-9601 and E-ISSN of 1873-961X, the journal is committed to disseminating high-quality research that informs both academic studies and practical applications in biotechnology and medicine. Although not an open access publication, it provides essential resources tailored for professionals, students, and researchers, enhancing their knowledge of critical signaling pathways that drive health and disease. The journal is located in the Netherlands, at VAN GODEWIJCKSTRAAT 30, DORDRECHT, and stands out in the field, boasting impressive ranks among its peers in the Scopus database.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Elevating Insights in Molecular Biology
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-9238Frequency: 6 issues/year

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

FEBS LETTERS

Where Innovation Meets Biological Discovery
Publisher: WILEYISSN: 0014-5793Frequency: 24 issues/year

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

JOURNAL OF BIOSCIENCES

Navigating the Landscape of Biosciences Since 1979
Publisher: INDIAN ACAD SCIENCESISSN: 0250-5991Frequency: 1 issue/year

JOURNAL OF BIOSCIENCES, published by the Indian Academy of Sciences, has established itself as a pioneering platform in the fields of biosciences, encompassing diverse research areas such as agricultural and biological sciences, biochemistry, genetics, molecular biology, and medicine. With an impressive trajectory since its inception in 1979, the journal has achieved notable recognition, securing a Q1 ranking in Agricultural and Biological Sciences and maintaining its place in the top quartiles for Biochemistry and Medicine as of 2023. With Scopus rankings placing it at #32 in General Agricultural and Biological Sciences and #65 in General Biochemistry, Genetics, and Molecular Biology, the journal reaches the 85th and 70th percentiles respectively, reflecting its impact and relevance in current scientific discourse. Although it does not offer open access, the JOURNAL OF BIOSCIENCES remains crucial for researchers, professionals, and students dedicated to advancing knowledge and innovation within the biosciences, providing a vibrant forum for high-quality research and comprehensive reviews.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Pioneering Research in Biochemistry and Cell Biology
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.